Wave Life Sciences Ltd (NASDAQ: WVE) stock enjoyed a major increase of 11.7% on 3/4/25. The shares closed at $11.23. Moreover, this advance was accompanied by exceptionally high trading volume at 236% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 7.2% during the last week.
Current PriceTarget Research Rating
Wave Life Sciences has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Wave Life Sciences has a very low Appreciation Score of 1 but a very high Power Rating of 92, resulting in the Low Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment